Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

The local, intramyocardial injection of proteins into the infarcted heart is an attractive option to initiate cardiac regeneration after myocardial infarction (MI). Liraglutide, which was developed as a treatment for type 2 diabetes, has been implicated as one of the most promising protein candidate...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Quan, Lu, Lei, Li, Haiqing, Yuan, Zhize, Chen, Gaoxian, Lin, Miao, Ruan, Zhengwen, Ye, Xiaofeng, Xiao, Zeyu, Zhao, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511023/
https://www.ncbi.nlm.nih.gov/pubmed/28744119
http://dx.doi.org/10.2147/IJN.S132064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511023/
https://www.ncbi.nlm.nih.gov/pubmed/28744119
http://dx.doi.org/10.2147/IJN.S132064

Ejemplares similares